Patents by Inventor Timothy Christian
Timothy Christian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9186113Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: GrantFiled: August 11, 2014Date of Patent: November 17, 2015Assignee: Abbott Diabetes Care Inc.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Publication number: 20150116333Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: January 8, 2015Publication date: April 30, 2015Applicant: Abbott Diabetes Care Inc.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Publication number: 20150073243Abstract: Methods and system to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided.Type: ApplicationFiled: November 12, 2014Publication date: March 12, 2015Applicant: Abbott Diabetes Care Inc.Inventors: Marc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
-
Patent number: 8924159Abstract: Methods and system to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided.Type: GrantFiled: June 1, 2009Date of Patent: December 30, 2014Assignee: Abbott Diabetes Care Inc.Inventors: Marc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
-
Publication number: 20140347186Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: ApplicationFiled: August 11, 2014Publication date: November 27, 2014Applicant: Abbott Diabetes Care Inc.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Publication number: 20140257059Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: ApplicationFiled: May 22, 2014Publication date: September 11, 2014Applicant: Abbott Diabetes Care Inc.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
-
Publication number: 20140243638Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.Type: ApplicationFiled: May 5, 2014Publication date: August 28, 2014Applicant: Abbott Diabetes Care Inc.Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
-
Patent number: 8816862Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: GrantFiled: August 19, 2013Date of Patent: August 26, 2014Assignee: Abbott Diabetes Care Inc.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
-
Publication number: 20140200426Abstract: Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.Type: ApplicationFiled: March 14, 2014Publication date: July 17, 2014Applicant: Abbott Diabetes Care Inc.Inventors: Marc Barry Taub, Jai Karan, Annie C. Tan, Timothy Christian Dunn, Joel Goldsmith, Christine M. Neuhaus, Stephen A. Rossi, Sujit R. Jangam
-
Publication number: 20140156204Abstract: Methods to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided. Systems to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided. Kits to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided.Type: ApplicationFiled: February 6, 2014Publication date: June 5, 2014Applicant: Abbott Diabetes Care Inc.Inventors: Marc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
-
Patent number: 8744547Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.Type: GrantFiled: July 9, 2012Date of Patent: June 3, 2014Assignee: Abbott Diabetes Care Inc.Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
-
Patent number: 8718739Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.Type: GrantFiled: December 28, 2012Date of Patent: May 6, 2014Assignee: Abbott Diabetes Care Inc.Inventors: Wesley Scott Harper, Timothy Christian Dunn, Erwin Satrya Budiman, Kenneth J. Doniger, Gary Alan Hayter
-
Publication number: 20140081104Abstract: Methods to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HblAC levels are provided. Systems to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HblAC levels are provided. Kits to provide glycemic control and therapy management based on monitored glucose data, and current and/or target HblAC levels are provided.Type: ApplicationFiled: November 25, 2013Publication date: March 20, 2014Applicant: ABBOTT DIABETES CARE INC.Inventors: Marc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
-
Patent number: 8591410Abstract: Methods to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided. Systems to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided. Kits to provide glycemic control and therapy management based on monitored glucose data, and current and/or target Hb1AC levels are provided.Type: GrantFiled: June 1, 2009Date of Patent: November 26, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Marc Barry Taub, Timothy Christian Dunn, Nathan Christopher Crouther
-
Patent number: 8583205Abstract: Methods, devices, and systems for calibrating an analyte sensor are provided. Embodiments include determining a sensitivity value associated with an analyte sensor, retrieving a prior sensitivity value associated with the analyte sensor, determining whether a variance between the determined sensitivity value and the retrieved prior sensitivity value is within a predetermined sensitivity range, determining a composite sensitivity value based on the determined sensitivity value and the retrieved prior sensitivity value, and assigning a successful calibration sensitivity value based on the retrieved prior sensitivity value when the variance is within the predetermined sensitivity range.Type: GrantFiled: April 16, 2010Date of Patent: November 12, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Erwin Satrya Budiman, Kenneth J. Doniger, Timothy Christian Dunn, Wesley Scott Harper
-
Patent number: 8514086Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.Type: GrantFiled: August 30, 2010Date of Patent: August 20, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Geoffrey V. McGarraugh, Michael Love, Phillip Yee, Gary Alan Hayter, Marc Barry Taub, Thomas A. Peyser, Michael A. Pani, R. Curtis Jennewine, Glenn Howard Berman
-
Patent number: D679814Type: GrantFiled: August 30, 2010Date of Patent: April 9, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Timothy Christian Dunn, Wesley Scott Harper, Annie C. Tan
-
Patent number: D679815Type: GrantFiled: August 30, 2010Date of Patent: April 9, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Timothy Christian Dunn, Wesley Scott Harper, Annie C. Tan
-
Patent number: D679816Type: GrantFiled: August 30, 2010Date of Patent: April 9, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Timothy Christian Dunn, Wesley Scott Harper, Annie C. Tan
-
Patent number: D689189Type: GrantFiled: August 30, 2010Date of Patent: September 3, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Timothy Christian Dunn, Wesley Scott Harper, Annie C. Tan